Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia
Medical College of Wisconsin
Medical College of Wisconsin
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
University of Rochester
Washington University School of Medicine
Northwestern University